News

A new cardiological medical product Agvistat®(combination of amlodipine with valsartan) in the form of a film-coated tablets with dosage units  of 5/160 mg and 10/160 mg (No28), produced by large National manufacturer VIVA PHARM LLC was registered by the order of a Chairman of the Control over medical and pharmaceutical activity Committee of the Ministry of health and social development of the Republic of Kazakhstan.

Product details